Cel-Sci Corporation Share Price
AMEX: CVM | Micro CapCel-Sci Corporation Stock Performance
Open $1.60 | Prev. Close $1.62 | Circuit Range N/A |
Day Range $1.53 - $1.60 | Year Range $0.90 - $12.51 | Volume 5,729 |
Average Traded $1.56 |
Cel-Sci Corporation Share Price Today
As of 29 August 2026, Cel-Sci Corporation's share price is $1.56. The stock opened at $1.60, compared to its previous close of $1.62. During today's trading session, Cel-Sci Corporation's share price traded between $1.53 and $1.60, with an average price of $1.57. Over the past 52 weeks, the stock has recorded a high of $12.51 and a low of $0.90. In terms of performance, Cel-Sci Corporation's share price has declined by 62.77% over the last six months and is down 85.17% on a year-on-year basis.
Cel-Sci Corporation Share Price Chart
Cel-Sci Corporation Stock Fundamentals & Key Indicators
Market Cap $6.33M | PE Ratio (TTM) -0.25 | Dividend Yield N/A |
EPS (TTM) $-6.27 | Revenue (TTM) N/A | Return On Equity (TTM) -159.25% |
Profit Margin N/A | Debt to Equity 0.32 | Quarterly Earnings Growth YoY 22.67% |
Cel-Sci Corporation Quarterly Profit & Loss
All figures in USD
Cel-Sci Corporation Annual Profit & Loss
All figures in USD
About Cel-Sci Corporation
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia.
Cel-Sci Corporation Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $1.19 | $1.62 | +39.06% |
Jul 2026 | $1.05 | $1.17 | +10.95% |
Jun 2026 | $1.46 | $1.05 | -31.82% |
May 2026 | $2.83 | $1.54 | -51.11% |
Apr 2026 | $3.38 | $3.15 | +3.28% |
Mar 2026 | $3.77 | $3.05 | -27.21% |
Feb 2026 | $5.48 | $4.19 | -27.13% |
Jan 2026 | $5.33 | $5.75 | +6.48% |
Dec 2025 | $7.11 | $5.40 | -29.60% |
Nov 2025 | $7.01 | $7.67 | +6.90% |
Oct 2025 | $9.29 | $7.17 | -22.10% |
Sep 2025 | $10.44 | $9.21 | -12.45% |
CVM Share Price FAQs
What is Cel-Sci Corporation share price today?
What is the 52 week high and 52 week low of Cel-Sci Corporation stock?
What is CVM's market capitalisation today?
What is CVM's net income for the last quarter?
What is the 5 year returns of CVM?
What is the high & low stock price of CVM today?
Can I buy CVM shares in India?